This website uses cookies

Some cookies are strictly necessary for the proper functioning of the website. Therefore you cannot unclick the corresponding box if you wish to visit the website. Other cookies are used for statistics and marketing purposes. We will not place them unless you agree by ticking the corresponding box. Here is a link our cookie policy

Cookies that the site cannot function properly without. This includes cookies for access to secure areas and CSRF security. Please note that Craft’s default cookies do not collect any personal or sensitive information. Craft's default cookies do not collect IP addresses. The information they store is not sent to Pixel & Tonic or any 3rd parties.
Name: CraftSessionId
Description: Craft relies on PHP sessions to maintain sessions across web requests. That is done via the PHP session cookie. Craft names that cookie “CraftSessionId” by default, but it can be renamed via the phpSessionId config setting. This cookie will expire as soon as the session expires.
Provider: this site
Expiry: Session
Name: *_identity
Description: When you log into the Control Panel, you will get an authentication cookie used to maintain your authenticated state. The cookie name is prefixed with a long, randomly generated string, followed by _identity. The cookie only stores information necessary to maintain a secure, authenticated session and will only exist for as long as the user is authenticated in Craft.
Provider: this site
Expiry: Persistent
Name: *_username
Description: If you check the "Keep me logged in" option during login, this cookie is used to remember the username for your next authentication.
Provider: this site
Expiry: Persistent
Name: CRAFT_CSRF_TOKEN
Description: Protects us and you as a user against Cross-Site Request Forgery attacks.
Provider: this site
Expiry: Session
Statistic cookies help us understand how visitors interact with websites by collecting and reporting information anonymously.
Marketing cookies are used to track visitors across websites. The intention is to display ads that are relevant and engaging for the individual user and thereby more valuable for publishers and third party advertisers.
Details Hide Details
COOKIES
  • Home
  • The Science
  • Nu.Q® Pipeline
    • Nu.Q®
    • Nu.Q® NETs
    • Nu.Q® Vet
    • Nu.Q® Capture
    • Nu.Q® Discover
  • About Us
    • Our Values
    • Our Expert Team
    • Careers
    • Contact Us
  • Investors
  • Resources
    • News Room
    • Scientific
    • Investors
    • Veterinary Resources
  • Join Mailing List
Volition
  • Home
  • The Science
  • Nu.Q® Pipeline
    • Nu.Q®
    • Nu.Q® NETs
    • Nu.Q® Vet
    • Nu.Q® Capture
    • Nu.Q® Discover
Volition
  • About Us
    • Our Values
    • Our Expert Team
    • Careers
    • Contact Us
  • Investors
  • Resources
    • News Room
      • Press Releases
      • In Focus
      • Video Gallery
      • Media Toolkit
      • Downloads
    • Scientific
      • Clinical Papers & Posters
      • Presentations
      • Video Gallery
    • Investors
      • Presentations
      • Video Gallery
    • Veterinary Resources
  • Join Mailing List
  1. Resources
  2. ᐳ
  3. Investors ᐳ
  4. Presentations
Presentations Video Gallery

Presentations.

Volition Corporate Deck March 2023 thumbnail
Mar 16, 2023

Volition Corporate Presentation March 2023

Download PDF

CMD Deck 2022
May 13, 2022

Capital Markets Day May 2022

Download PDF

Volition 2021 Financial Results Thumbnail March 2022
Mar 31, 2022

Volition 2021 Financial Results & Business Update Presentation March 2022

Download PDF

VVDD Nov 2020 Thumbnail Images
Nov 19, 2020

Volition Veterinary Diagnostics Development LLC Presentation - November 2020

Download PDF

  • Contact Us
  • Downloads
  • eIFU Resources
  • Privacy Policy
  • Cookies Policy
  • Disclaimer
  • Manage Cookie Preferences
Sign up to email alerts
linkedin facebook twitter

The European Regional Development Fund and Wallonia are investing in your future

http://europe.wallonie.be

The European Regional Development Fund and Wallonia are investing in your future

http://europe.wallonie.be

MENAC - Epigenetic Modifications of Nucleosomes Associated with Cancer

Thanks to a grant of 1.990.798€ from the European Regional Development Fund and Walloon Government, we’re taking part in the MENAC project which aims to develop innovative non-invasive tests for the early detection of different types of cancer. We’re working in partnership with Synabs to create monoclonal antibodies and develop new diagnostic and theragnostic immunoassays.